MedPage Today (1/31, George) reports, “Prevalence of abnormal amyloid was about 10% higher than previously estimated among people with normal cognition, updated data from the Amyloid Biomarkers Study indicated.” According to the researchers, “across 19,000 people in 85 cohorts, those without dementia had higher amyloid abnormality prevalence when adjusted data-driven cutoffs of cerebrospinal fluid…measures were used, suggesting preclinical and prodromal Alzheimer’s disease could be more prevalent than once thought.” The data were published in JAMA Neurology. (SOURCE: APA Headlines)